Latest publications

Lyngstad G, Skjelbred P, Swanson DM, Skoglund LA (2024)
Correction to: Analgesic effect of oral paracetamol 1000 mg/ibuprofen 400 mg, paracetamol 1000 mg/codeine 60 mg, paracetamol 1000 mg/ibuprofen 400 mg/codeine 60 mg, or placebo on acute postoperative pain: a single‑dose, randomized, and double‑blind study
Eur J Clin Pharmacol (in press)
DOI 10.1007/s00228-024-03688-4, PubMed 38653785

Łosińska K, Pripp AH, Bakland G, Fevang BS, Brekke LK, Wierød A, Korkosz M, Haugeberg G (2024)
Comparative effectiveness and persistence of SB4 and reference etanercept in patients with psoriatic arthritis in Norway
Arthritis Care Res (Hoboken) (in press)
DOI 10.1002/acr.25345, PubMed 38600298

Kjørholt KE, Sundlisæter NP, Aga AB, Sexton J, Olsen IC, Fremstad H, Spada C, Madland TM, Høili CA, Bakland G, Lexberg Å, Hansen IJW, Hansen IM, Haukeland H, Ljoså MA, Moholt E, Uhlig T, Kvien TK, Solomon DH, van der Heijde D, Haavardsholm EA, Lillegraven S (2024)
Effects of tapering conventional synthetic disease-modifying antirheumatic drugs to drug-free remission versus stable treatment in rheumatoid arthritis (ARCTIC REWIND): 3-year results from an open-label, randomised controlled, non-inferiority trial
Lancet Rheumatol (in press)
DOI 10.1016/S2665-9913(24)00021-3, PubMed 38583450